Abstract 12077: Abbreviation of Eptifibatide Therapy Improves Safety in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

Florian Fischer,Samriddhi Buxy,Ulrike Held,David J. Kurz,Oliver Senn,Franz R. Eberli,Rainer Zbinden,Matthias R. Meyer

Abstract 12077: Abbreviation of Eptifibatide Therapy Improves Safety in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention

2019

Florian Fischer
Samriddhi Buxy
Ulrike Held
David J. Kurz
Oliver Senn
Franz R. Eberli
Rainer Zbinden
Matthias R. Meyer

Introduction: The glycoprotein IIb/IIIa inhibitor eptifibatide, administered as bolus followed by infusion, is a recommended adjunctive antithrombotic therapy during primary PCI in STEMI patients. ...

Keywords:

Cardiology
Internal medicine
Eptifibatide
Percutaneous coronary intervention
Antithrombotic
Bolus (digestion)
Conventional PCI
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations